Moderna
MRNA
#1757
Rank
NZ$19.84 B
Marketcap
NZ$50.79
Share price
-0.57%
Change (1 day)
-29.95%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -NZ$5.46 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$2.20 Billion. In 2024 the company made an earning of -NZ$6.18 Billion, an increase over its 2023 earnings that were of -NZ$6.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$5.46 Billion-11.75%
2024 -NZ$6.18 Billion-8.22%
2023 -NZ$6.74 Billion-140.65%
2022 NZ$16.55 B-27.81%
2021 NZ$22.93 B-1911.15%
2020 -NZ$1.27 Billion44.7%
2019 -NZ$0.88 Billion28.63%
2018 -NZ$0.69 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-NZ$81.77 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.80 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$72 Million-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.22 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.30 B-622.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
-NZ$0.13 Billion-97.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.84 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA